Skip to main content
logo
Faeth Therapeutics, Inc. (FTH)
NASDAQ: FTH · Real-Time Price · USD
32.00
-0.10 (-0.31%)
Aug 21, 2026, 4:00 PM EDT - Market closed

Faeth Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
82713121746177
Market Cap Growth
8137.13%9.18%-28.74%-62.21%-74.21%-
Enterprise Value
641-10-30-48-6222
Last Close Price
32.0010.679.8013.8429.80116.00

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PB Ratio
4.780.720.320.270.441.21
P/TBV Ratio
4.780.720.320.270.441.21

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
0.000.080.100.100.080.02
Net Debt / Equity Ratio
-1.07-1.06-0.98-0.92-0.96-0.99
Net Debt / EBITDA Ratio
5.070.891.241.672.033.95
Net Debt / FCF Ratio
5.490.961.511.852.524.50
Quick Ratio
19.464.987.5911.6511.8230.20
Current Ratio
19.695.067.7011.9211.9830.38
Return on Equity (ROE)
-195.26%-74.01%-58.40%-40.52%-38.88%-45.31%
Return on Assets (ROA)
-20.79%-40.81%-33.05%-24.04%-23.10%-26.83%
Return on Capital Employed (ROCE)
-20.50%-119.50%-79.30%-53.90%-45.90%-25.30%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-23.65%-156.67%-244.65%-197.14%-106.15%-20.73%
FCF Yield
-4.10%-152.10%-201.32%-186.17%-85.96%-18.19%
Buyback Yield / Dilution
-88.34%-0.40%10.15%8.96%-10.80%-1618.88%
SEC Filings: 10-K · 10-Q